和其瑞医药（南京）有限公司 Heqirui Pharmaceutical (Nanjing) Co. LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia 2024-01-15 08:08
Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in Androgen Alopecia 2022-01-26 08:00
Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer 2021-08-30 08:00
Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation 2021-05-06 08:00
Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development 2020-12-14 09:00
1